Search Results for "alzheimer's screening"
Guardian jumps to conclusions about an Alzheimer’s study that hasn’t even begun
The story’s headline states: “Virtual reality to help detect early risk of Alzheimer’s.” That is misleading. The researchers haven’t even recruited study participants yet, much less conducted the study or analyzed the results.
Virtual reality to help detect early risk of Alzheimer’s
Shameless Alzheimer’s sales pitch masquerades as solid science
In the annals of unsavory attempts to exploit vulnerable people with false hope, a new campaign to promote an unproven supplement said to slow the progression of Alzheimer’s disease ranks near the lowest of the low. A PR company working with the supplement maker is attempting to attract the attention of journalists with claims based […]
3
How the ‘optimism’ narrative in Alzheimer’s helps the drug industry and harms patients
When I think about what will be lost when HealthNewsReview.org closes its doors at the end of 2018, our emphasis on independent expert assessment of health care claims looms as one of the biggest deficits. We’ve pointed out time and again how health care news can be tainted by the influence of industry and hidden […]
Diagnosing Alzheimer’s using biomarkers–AP makes it clear that there is no benefit to patients
Still, we would have liked to see comment from an independent source on how this news might be misconstrued, especially by readers worried about their own risk for developing the disease.
New way of defining Alzheimer's aims to find disease sooner
‘Daily ibuprofen can prevent Alzheimer’s disease’ and other unproven claims by Canadian neuroscientist
The news release suggests that the way to diagnose Alzheimer’s disease early is by looking for elevated levels of Abeta42 in the saliva, thereby allowing early treatment with ibuprofen. However, no data on the accuracy of this screening method is included.
Canadian neuroscientists say daily ibuprofen can prevent Alzheimer's disease
‘$7.9 trillion’ savings from earlier Alzheimer’s diagnosis: Is there a hidden agenda behind the numbers?
More disease advocacy organizations are enlisting business consulting groups to conduct research to further their causes and, not coincidentally, those of their pharmaceutical company sponsors. This week the strategy paid off for the Alzheimer’s Association: An article in Bloomberg News headlined “Spotting Alzheimer’s Early Could Save America $7.9 Trillion” came from the annual Facts and […]
Retinal imaging detects biomarker for Alzheimer’s: Novel yes, but practical?
Great descriptions on a novel test needed more data to buoy diagnostic claims.
Clinical study shows that retinal imaging may detect signs of Alzheimer's disease
Why statins probably don’t reduce risk of Alzheimer’s disease, despite what headlines say
Did you know that growth in the per capita consumption of mozzarella cheese in the U.S. is almost exactly correlated to the rise in Americans who earned their doctorate degrees in civil engineering? Or that the annual tally of the number of people who drowned by falling into a swimming-pool correlates with the number of […]
Can an Alzheimer’s drug help you quit smoking? Penn PR release nicely frames very early research
Generally solid discussion of an early study on repurposing an Alzheimer’s drug to help with smoking cessation.
Penn research: An FDA-approved Alzheimer's drug could help smokers quit
Predicting Alzheimer’s: What two new studies add and how the Times covered them
This story sends readers off with the right take-home message, but could have done with a few more caveats and a better look at the big picture regarding the role of amyloid in Alzheimer’s disease.
Studies Confirm Brain Plaque Can Help Predict Alzheimer’s
On Alzheimer’s study, standout stories evaluated both evidence & ethics
A study published in Nature Medicine is sending journalists tumbling over each other with enthusiasm for claims that a blood test could help predict Alzheimer’s disease. Dozens and dozens of stories reported the study with no independent scientific perspective and with little or no discussion of the ethics questions involved in an Alzheimer’s test – […]
1 10/14/2013News coverage of peanut butter Alzheimer’s test doesn’t stick
CBS News online actually asked whether a scoop of peanut butter and a ruler could become the “elusive”…”single..definitive test” that could determine whether a person has Alzheimer’s disease. I was away when this was published, but Ivan Oransky was all over it on MedPageToday.com. Excerpts of his analysis: Reading CBS News’s headline, “Cheap Alzheimer’s Test […]
1/15/2013The media are influential…on everyone else, say Alzheimer’s specialists
Nice catch by my colleague Andrew Holtz (one of our story reviewers on HealthNewsReview.org) as he combed the literature and settled on a paper in the Journal of Alzheimer’s Disease entitled, “Dementia Specialists and Early Adoption of Amyloid Imaging.” With Andrew’s permission, I am reposting his piece in its entirety. ————————————————— A new survey of […]
12/28/2010A leading health policy issue for 2010-11: communicating tradeoffs in screening test decisions
One trend that stands out from 2010 is what I call screening madness. I’m referring specifically and solely to the promotion of screening tests outside the boundaries of evidence and to the emphasis only on the benefits of screening tests with concomitant downplaying or complete disregard for the harms of screening. Why is this a […]
6 11/2/2010Screening for Alzheimer's: What Good Can It Do?
I could write about different screening test controversies every day and not get caught up (but, indeed, may have a screening-post-of-the-day every day this week). Alan Cassels, a drug policy researcher and author at the University of Victoria, British Columbia, and publisher of the Media Doctor Canada website (sibling to our HealthNewsReview.org site), has published […]
